IDH1 and glioma: According to the WHO classification of 2016, three major diagnostic subtypes of gliomas are individualized in three groups: (i) IDH-mutant, (ii) IDH-wildtype for most comprising GBM, and (iii) IDH not otherwise specified (Louis et al., 2016).